|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Report From the Extraordinary General Meeting of Vitrolife Held on September 24, 2012
9/24/2012 10:04:30 AM
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife AB (STO:VITR):
1. The meeting adopted a resolution to distribute shares in the subsidiary Xvivo Perfusion AB to company shareholders, whereby one (1) existing share in Vitrolife AB entitles shareholders to distribution of one (1) share in Xvivo Perfusion AB. After the shareholders’ contribution of SEK 65,400,000 from Vitrolife AB, Xvivo Perfusion AB has a book value of SEK 65,518,757, which corresponds to a figure of approximately SEK 3.35 per share. After the shareholders’ contribution has been completed, SEK 113,799,910 remains of the unappropriated amount in accordance with chap.17 § 3, paragraph one of the Swedish Companies Act. The last day for trade in Vitrolife shares with entitlement to the distribution of shares in Xvivo is September 26 The record day is October 1.The record day is October 1, 2012.
|
|
|
|
|
|
|
|
|
|
|